Drugs / TRYP-0082
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05035927 | Mar 2022 → Mar 2024 | binge eating disorder | TRYP Therapeutics | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TRYP-0082 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05035927 ↗ |
| Route | Oral | “A single (1) 25 mg oral dose of TRP 8802 will be administered in a carefully monitored setting” NCT05035927 ↗ |